DJIA 16,058.35 -469.68 -2.84%
NASDAQ 4,636.11 -140.40 -2.94%
S&P 500 1,913.85 -58.33 -2.96%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

10.51 -0.26 (-2.41%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVAX $10.51 -2.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.38
Previous Close $10.77
Daily Range $10.08 - $10.61
52-Week Range $3.92 - $15.01
Market Cap $2.8B
P/E Ratio -26.93
Dividend (Yield) $0.00 (0.0%)
Volume 11,121,785
Average Daily Volume 5,425,820
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drug Makers

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary Rss Feed

Can Novavax Inc.'s Stock Inoculate Your Portfolio From More Market Mayhem?

This small-cap clinical-stage biopharma company is on a stellar run this year. Can it continue?

PJP, DEPO, NVAX, MDCO: Large Outflows Detected at ETF

Benzinga's Top #PreMarket Losers

Interesting NVAX Put And Call Options For April 2016

Novavax to Host 3rd Annual Analyst and Investor Meeting on Tuesday, September 29, 2015 from 9:00 a.m

Novavax to Host 3rd Annual Analyst and Investor Meeting on Tuesday, September 29, 2015 from 9:00 a.m. - 11:00 a.m. ET

4 Biotechs Piper Jaffray Is Buying On The Pullback

How I made money when the Dow lost 1,000 points

I made money when the Dow lost 1,000 points

Jim Cramer's Top Takeaways: Novavax, Cisco, Freshpet, Macy's

Novavax Breathing Easier With Positive RSV Data

Novavax (NVAX) Shows Strength: Stock Moves Up 24.1%

See More NVAX News...

NVAX's Top Competitors

NVAX $10.51 (-2.41%)
Current stock: NVAX
AMGN $147.46 (-2.85%)
Current stock: AMGN
GILD $101.49 (-3.41%)
Current stock: GILD
BIIB $292.50 (-1.61%)
Current stock: BIIB